Endothelial Activation Predicts Disseminated Intravascular Coagulopathy, Cytokine Release Syndrome and Prognosis in Patients Treated with Anti-CD19 CAR-T Cells

In 38 consecutive patients with aggressive lymphoproliferative disease investigators measured a coagulative laboratory panel at baseline and early after infusion of anti-CD19 CAR-T.